drugset / Trial / NCT02493257
Intranasal Capsaicin Treatment for Non-Allergic Irritant Rhinitis
Phase 2
Completed
22 enrolled
The University of Texas Health Science Center, Houston
American Academy of Otolaryngic Allergy · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The proposed study seeks to investigate the effect of intranasal capsaicin treatment in patient with Non-allergic irritant rhinitis (NAIR), as well as evaluate optical rhinometry (ORM) as a means to quantify symptomatic improvement in NAIR patients during and after treatment.
Timeline
- Start
- 2014-10
- Primary completion
- 2019-08-02
- Completion
- 2019-08-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capsaicin | Small molecule | 24.4 ug | Intranasal |
| Subject | Capsaicin | Small molecule | 0.8 ml | Intranasal |